Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Dimension Capital Ii, L.p.

Over the trailing 90 days, Dimension Capital Ii, L.p. (Director at Odyssey Therapeutics, Inc.) bought $20.0M of stock in ODTX, per 3 SEC Form 4 transactions.

Role: Director
Companies: ODTX
Window: Trailing 90 days · 3 transactions · CIK 2040933
Net activity: +$20.0M ($20.0M bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
ODTX	Odyssey Therapeutics, Inc.	3	$20.0M	—	$20.0M

Transactions (3)

Date	Symbol	Type	Shares	Value	Description
2026-05-08	ODTX	Buy	1.1M	$20.0M	Open market or private purchase
2026-05-08	ODTX	Buy	1.7M	$0	Conversion of derivative security
2026-05-08	ODTX	Sell	16.6M	$0	Conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Dimension's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free